{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:27:13Z","timestamp":1768883233782,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006181","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado da Bahia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118080","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T17:17:56Z","timestamp":1745687876000},"page":"118080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ru(II)-thymine complex suppresses acute myeloid leukemia stem cells by inhibiting NF-\u03baB signaling"],"prefix":"10.1016","volume":"187","author":[{"given":"Maiara de S.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid R.S.B.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela G.A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina B. da C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suellen L.R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena B.P.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane B.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-6128","authenticated-orcid":false,"given":"Ludmila F.","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa A.","family":"Gurgel Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alzir A.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo S.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdenizia R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-140X","authenticated-orcid":false,"given":"Eug\u00eania T.","family":"Granado Pina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-2063","authenticated-orcid":false,"given":"Daniel P.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2025.118080_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2025.118080_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"10393","key":"10.1016\/j.biopha.2025.118080_bib3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118080_bib4","unstructured":"American Cancer Society: Cancer Facts and Figures 2024. American Cancer Society, 2024. Available online at \u3008https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2024\/2024-cancer-facts-and-figures-acs.pdf\u3009. Last accessed June 21, 2024."},{"key":"10.1016\/j.biopha.2025.118080_bib5","unstructured":"Surveillance, Epidemiology, and End Results Program: Cancer Stat Facts: Leukemia \u2014 Acute Myeloid Leukemia (AML). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, 2020. Available online at \u3008https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html\u3009. Last accessed October 5, 2023."},{"key":"10.1016\/j.biopha.2025.118080_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103277","article-title":"Cell signaling pathways as molecular targets to eliminate AML stem cells","volume":"160","author":"Rodrigues","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118080_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2022.280800","article-title":"Leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"108","author":"Stelmach","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118080_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102692","article-title":"Emerging drugs targeting cellular redox homeostasis to eliminate acute myeloid leukemia stem cells","volume":"62","author":"Costa","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118080_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1204895","article-title":"Therapeutic targeting of leukemia stem cells in acute myeloid leukemia","volume":"13","author":"Barbosa","year":"2023","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118080_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.annonc.2020.02.018","article-title":"ESMO guidelines committee. acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Heuser","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118080_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biopha.2025.118080_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.897220","article-title":"Treatment options for acute myeloid leukemia patients aged <\u200960 years","volume":"12","author":"Visani","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118080_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fonc.2019.00582","article-title":"Ruthenium complexes with piplartine cause apoptosis through MAPK signaling by a p53-dependent pathway in human colon carcinoma cells and inhibit tumor development in a xenograft model","volume":"9","author":"Baliza","year":"2019","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47914-x","article-title":"Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK\/p38 pathways in human acute promyelocytic leukemia cells","volume":"9","author":"Bomfim","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41420-023-01759-6","article-title":"A novel ruthenium complex with 5-fluorouracil suppresses colorectal cancer stem cells by inhibiting Akt\/mTOR signaling","volume":"9","author":"Silva","year":"2023","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.biopha.2025.118080_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41419-023-06330-w","article-title":"New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone","volume":"14","author":"Santos","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118080_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117059","article-title":"Ruthenium complex containing 1,3-thiazolidine-2-thione inhibits hepatic cancer stem cells by suppressing Akt\/mTOR signalling and leading to apoptotic and autophagic cell death","volume":"177","author":"Neves","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41420-024-02036-w","article-title":"Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-\u03baB and Akt\/mTOR signaling","volume":"10","author":"Bomfim","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13046-023-02931-7","article-title":"Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy","volume":"43","author":"Alcal\u00e1","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2025.118080_bib20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1039\/D3CC05083A","article-title":"A bis-quinoline ruthenium(II) arene complex with submicromolar cytotoxicity in castration-resistant prostate cancer cells","volume":"60","author":"Khan","year":"2024","journal-title":"Chem. Commun."},{"issue":"13","key":"10.1016\/j.biopha.2025.118080_bib21","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1021\/acs.jmedchem.4c00406","article-title":"2-Aryl-1H-imidazo[4,5-f][1,10]phenanthroline-based binuclear Ru(II)\/Ir(III)\/Re(I) complexes as mitochondria targeting cancer stem cell therapeutic agents","volume":"67","author":"Kar","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118080_bib22","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1039\/C7NJ04368F","article-title":"Ru(II)-thyminate complexes: New metallodrug candidates against tumor cells","volume":"42","author":"Correa","year":"2018","journal-title":"N. J. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118080_bib23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3390\/ijms19061609","article-title":"Ru(II)-thymine complex causes cell growth inhibition and induction of caspase-mediated apoptosis in human promyelocytic leukemia HL-60 cells","volume":"19","author":"Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47539-0","article-title":"Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK\/p38\/ERK1\/2 via a p53-independent signaling","volume":"9","author":"Silva","year":"2019","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.biopha.2025.118080_bib25","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1182\/bloodadvances.2020001742","article-title":"Delineation of target expression profiles in CD34+\u2009\/CD38- and CD34+\u2009\/CD38+\u2009stem and progenitor cells in AML and CML","volume":"4","author":"Herrmann","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.biopha.2025.118080_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2011.12.017","article-title":"Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity","volume":"318","author":"She","year":"2012","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.biopha.2025.118080_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","article-title":"The moonlighting enzyme CD13: old and new functions to target","volume":"14","author":"Mina-Osorio","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118080_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2014.04.001","article-title":"The past and future of CD33 as therapeutic target in acute myeloid leukemia","volume":"28","author":"Laszlo","year":"2014","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.biopha.2025.118080_bib29","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1080\/10428194.2021.1927021","article-title":"Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy","volume":"62","author":"Patnaik","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.biopha.2025.118080_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0022-1759(95)00172-7","article-title":"YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability","volume":"185","author":"Idziorek","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2025.118080_bib31","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014479","article-title":"The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis","volume":"296","author":"Mashimo","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118080_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu Rev. Genet"},{"issue":"12","key":"10.1016\/j.biopha.2025.118080_bib33","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118080_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.biopha.2025.118080_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41598-019-57172-6","article-title":"Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis","volume":"10","author":"Vegi","year":"2020","journal-title":"Sci. Rep."},{"issue":"36","key":"10.1016\/j.biopha.2025.118080_bib37","doi-asserted-by":"crossref","first-page":"60188","DOI":"10.18632\/oncotarget.19028","article-title":"Flexible ligated ruthenium(II) self-assemblies sensitizes glioma tumor initiating cells in vitro","volume":"8","author":"Elumalai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118080_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejmech.2018.07.048","article-title":"Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]2+\u2009co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells","volume":"156","author":"Purushothaman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118080_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101042","article-title":"Inhibition of NF-\u03baB signaling unveils novel strategies to overcome drug resistance in cancers","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"8","key":"10.1016\/j.biopha.2025.118080_bib41","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.celrep.2018.10.071","article-title":"Constitutive activation of the canonical NF-\u03baB pathway leads to bone marrow failure and induction of erythroid signature in hematopoietic stem cells","volume":"25","author":"Nakagawa","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1084\/jem.20181505","article-title":"Cohesin-mediated NF-\u03baB signaling limits hematopoietic stem cell self-renewal in aging and inflammation","volume":"216","author":"Chen","year":"2019","journal-title":"J. Exp. Med"},{"issue":"8","key":"10.1016\/j.biopha.2025.118080_bib43","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1182\/blood.V98.8.2301","article-title":"Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells","volume":"98","author":"Guzman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118080_bib44","unstructured":"ATCC Animal Cell Culture Guide: Get time-tested tips for culturing ATCC animal cells. Available at: \u3008https:\/\/www.atcc.org\/resources\/culture-guides\/animal-cell-culture-guide\u3009."},{"key":"10.1016\/j.biopha.2025.118080_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2025.118080_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.ima03bs111","article-title":"Trypan blue exclusion test of cell viability","volume":"111","author":"Strober","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.biopha.2025.118080_bib47","unstructured":"Cell Signaling Technology Flow Cytometry Live Cell Protocol. Available at: \u3008https:\/\/www.cellsignal.com\/learn-and-support\/protocols\/protocol-flow-live-cell\u3009."},{"key":"10.1016\/j.biopha.2025.118080_bib48","unstructured":"Cell Signaling Technology Flow Cytometry, Methanol Permeabilization Protocol. Available at: \u3008https:\/\/www.cellsignal.com\/learn-and-support\/protocols\/protocol-flow-methanol-permeabilization\u3009."},{"issue":"2","key":"10.1016\/j.biopha.2025.118080_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2025.118080_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1097-0320(19970501)28:1<74::AID-CYTO9>3.0.CO;2-H","article-title":"Mitochondrial membrane potential measurement in rat cerebellar neurons by flow cytometry","volume":"28","author":"Sureda","year":"1997","journal-title":"Cytometry"},{"issue":"3","key":"10.1016\/j.biopha.2025.118080_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.19","article-title":"A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia","volume":"5","author":"Saland","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biopha.2025.118080_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4939-1062-5_27","article-title":"SYBR\u00ae Green and TaqMan\u00ae quantitative PCR arrays: expression profile of genes relevant to a pathway or a disease state","volume":"1182","author":"Alvarez","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118080_bib53","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:55:20Z","timestamp":1759002920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"alternative-id":["S0753332225002744"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118080","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ru(II)-thymine complex suppresses acute myeloid leukemia stem cells by inhibiting NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118080"}}